Novartis Investigative Site

Cairo 12655

0 studies enrolling now · 12 studies all time

What they study most

Acute Heart Failure, Adenocarcinoma, Breast Cancer, Carcinoma, Cardiovascular Disease and Lipoprotein(a), Chronic Severe Plaque-type Psoriasis, Diffuse Large B-cell Lymphoma, Gastrointestinal Stromal Tumor (GIST), Hypernephroid, Liver Transplantation, Myelogenous Leukemia, Chronic, Nephroid Carcinoma

Studies at this site

• Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis — Completed
• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis — Completed
• A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) — Completed
• Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants — Completed
• Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer — Completed
• Global Non-interventional Heart Failure Disease Registry — Stopped early
• Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy — Completed
• Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole — Completed
• Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer — Completed
• A Study of Nilotinib Versus Imatinib in GIST Patients — Completed
• Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis — Stopped early